secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0001193125-24-097728
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Viridian Therapeutics amends lease for new headquarters suite, extends term 5 years
--------------------------------------------------------------------------------

- Fourth Amendment to Lease for 10,427 rentable sq ft at 221 Crescent St, Waltham, MA.
- Base rent starts at $38,232/month in first year, escalating ~2% annually over extended term.
- Tenant improvement allowance of up to $104,270; three-year extension option and right of first refusal granted.
- Replaces prior lease of 10,956 sq ft in a different suite at the same address.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312524097728/0001193125-24-097728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312524097728/d769681d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-097728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer